Get the Stockscreener App
1.59
16.75%
-0.32
Pre-market:
1.67
0.08
+5.03%
Cibus Inc stock is traded at $1.59, with a volume of 731.34K.
It is down -16.75% in the last 24 hours and down -49.68% over the past month.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
See More
Previous Close:
$1.91
Open:
$1.86
24h Volume:
731.34K
Relative Volume:
1.33
Market Cap:
$121.11M
Revenue:
$3.64M
Net Income/Loss:
$-132.20M
P/E Ratio:
-0.5334
EPS:
-2.9806
Net Cash Flow:
$-51.17M
1W Performance:
-19.70%
1M Performance:
-49.68%
6M Performance:
+11.19%
1Y Performance:
+0.00%
1-Day Range:
$1.58
$1.86
1-Week Range:
$1.58
$2.06
52-Week Range:
$1.09
$4.1907
Cibus Inc Stock (CBUS) Company Profile
Name
Cibus Inc
Sector
Industry
Phone
(858) 450-0008
Address
6455 NANCY RIDGE DRIVE, SAN DIEGO
Compare CBUS vs VRTX, REGN, ARGX, ALNY, INSM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CBUS
Cibus Inc
|
1.59 | 121.11M | 3.64M | -132.20M | -51.17M | -2.9806 |
VRTX
Vertex Pharmaceuticals Inc
|
431.86 | 109.85B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
760.27 | 80.38B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
765.43 | 47.60B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
319.52 | 42.63B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
163.03 | 35.19B | 606.42M | -1.28B | -997.58M | -6.403 |
Cibus Inc Stock (CBUS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-29-24 | Initiated | Alliance Global Partners | Buy |
| Jul-19-24 | Resumed | Canaccord Genuity | Buy |
| Oct-09-23 | Initiated | H.C. Wainwright | Buy |
| Jul-19-23 | Resumed | Canaccord Genuity | Buy |
Cibus Inc Stock (CBUS) Latest News
Cibus (CBUS) Sr VP withholds 1,763 shares for taxes, holds 101,879 - Stock Titan
Cibus (CBUS) CLO has 3,695 shares withheld to cover taxes - Stock Titan
Cibus (NASDAQ: CBUS) CFO reports 3,676-share tax-withholding disposition - Stock Titan
Cibus (NASDAQ: CBUS) CSO disposes 8,954 shares for tax withholding - Stock Titan
Cibus (CBUS) interim CEO Beetham disposes 16,112 shares for tax withholding - Stock Titan
Cibus, Inc. (NASDAQ:CBUS) Q4 2025 earnings call transcript - MSN
Pharma News: Whats the RSI of Cibus Inc stockQuarterly Portfolio Report & Precise Buy Zone Identification - baoquankhu1.vn
What is HC Wainwright's Forecast for Cibus FY2029 Earnings? - MarketBeat
Cibus Launches Underwritten Public Offering of Common Stock - The Globe and Mail
Cibus announces public offering of Class A common stock and pre-funded warrants - MSN
Cibus launches underwritten offering of 6.98M shares at $2.15 to raise about $13.5M - TradingView
Cibus (CBUS) prices underwritten stock sale, targeting up to $16M net - Stock Titan
Cibus prices $15 million public offering at $2.15 per share By Investing.com - Investing.com South Africa
Cibus (NASDAQ: CBUS) sells 6.98M Class A shares at $2.15 each - stocktitan.net
Analysts Conflicted on These Healthcare Names: Cibus (CBUS), Arrowhead Pharmaceuticals (ARWR) and Tarsus Pharmaceuticals (TARS) - The Globe and Mail
Cibus stock dips after pricing $15M offering - MSN
Cibus announces underwritten public offering of Class A shares By Investing.com - Investing.com Australia
Cibus prices $15 million public offering at $2.15 per share - Investing.com
Cibus sells nearly 7M shares to fund rice weed-trait development - Stock Titan
CIBUS, INC. ANNOUNCES PRICING OF PUBLIC OFFERING OF CLASS A COMMON STOCK - Moomoo
Jefferies Financial Group Issues Positive Forecast for Cibus (NASDAQ:CBUS) Stock Price - Defense World
Cibus announces Class A common stock offering, no amount given - TipRanks
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Cibus (NASDAQ: CBUS) seeks capital via Class A shares and pre-funded warrants - Stock Titan
Cibus announces underwritten public offering of Class A shares - investing.com
Cibus, Inc. Announces Proposed Public Offering of Class A Common Stock and Pre-Funded Warrants - The Manila Times
Cibus, Inc. Announces Proposed Public Offering Of Class A Common Stock And Pre-Funded Warrants - TradingView
Cibus seeks new capital for rice weed-trait work through stock sale - Stock Titan
Cibus (CBUS) Sees Analyst Laurence Alexander Raise Price Target - GuruFocus
Cibus (NASDAQ:CBUS) Price Target Raised to $3.00 at Jefferies Financial Group - MarketBeat
Cibus price target raised to $3 from $1.90 at Jefferies - TipRanks
Stock Report: Is Cibus Inc stock risky to hold nowPortfolio Risk Report & Pattern Based Trade Signal System - baoquankhu1.vn
Sidoti Brokers Increase Earnings Estimates for Cibus - MarketBeat
CBUS Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Cibus, Inc. (NASDAQ:CBUS) Q4 2025 Earnings Call Transcript - Insider Monkey
Cibus, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Cibus, Inc. Earnings Call Signals Promise Amid Pressure - tipranks.com
Cibus Q4 Earnings Call Highlights - MarketBeat
Cibus (CBUS) Q4 2025 Earnings Call Transcript - AOL.com
Cibus Inc: Sr VP Sauer sells $5 in stock By Investing.com - Investing.com India
Cibus Inc: Sr VP Sauer sells $5 in stock - Investing.com
Cibus (CBUS) CFO logs small 1,496-share tax-withholding disposition - Stock Titan
Cibus (CBUS) SVP reports minor share sale and tax withholding - Stock Titan
Cibus (NASDAQ: CBUS) CLO reports 13,109-share tax-withholding dispositions - Stock Titan
Cibus Inc. Accelerates Crop Productivity with Proprietary Gene Editing Technologies and Rapid Trait Development System (RTDS) - Minichart
Cibus Inc Stock (CBUS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.47%
2.75%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):